No Data
No Data
Express News | Beigene Announces Updates to Commercial Leadership Team
BeiGene Announces Updates to Commercial Leadership Team
BeiGene Highlights TEVIMBRA Data in Lung and Gastrointestinal Cancers at ESMO 2024
gtja: The pharmaceutical sector has differentiated in the first half of the year, and the improvement trend of innovative leaders is significant.
In the first half of the year, the performance of the pharmaceutical sector continues to diverge, with outstanding performance in chemical medicine and biopharmaceuticals. Among them, innovative themes are even better, traditional Chinese medicine and circulation are slightly under pressure in the short term, with valuations still at a temporarily low level. Bullish on bottom allocation value, bullish on leading sub-sectors.
Beigene (06160): The employee stock purchase plan for 2018 has started a new subscription period.
Beigene (06160) announced a new round of subscription period for the 2018 employee stock purchase plan from September 3, 2024...
BeiGene Grants Share Options, RSUs Under Incentive Plan